Meyka Pro banner
Accolade, Inc.

Accolade, Inc. (ACCD) Stock Overview

Explore Accolade, Inc.’s financial performance, market position, analyst ratings, and future outlook.

ACCDNASDAQ
HealthcareMedical - Healthcare Information Services
$7.02
$0.00(0.00%)
U.S. Market opens in 63h 27m

Accolade, Inc. (ACCD)

Meyka AI Score

Z

Key Financials

Market Cap575.6M
P/E Ratio-5.28
EPS (TTM)$-2.28
ROE-0.22%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

ACCD Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Accolade, Inc. (NASDAQ: ACCD) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Accolade, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of ACCD on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind Accolade, Inc.'s NASDAQ-traded stock include a P/E ratio of -5.28 and a market capitalization of 575.6M. Combined with our AI analysis, these give both institutional and retail investors a clear view of ACCD on the NASDAQ.

Price Performance (NASDAQ: ACCD)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
2.03%
6-Month Change
97.19%
Year-to-Date (YTD) Change
105.26%
1-Year Change
-1.40%
3-Year Change
28.81%
5-Year Change
1176.36%
All-Time (Max) Change
1176.36%

Contact Information

206 926 8100
660 West Germantown Pike, Plymouth Meeting, PA, 19462

Company Facts

24,000 Employees
IPO DateJul 1, 2020
CountryUS

Frequently Asked Questions